Stochter
Profile Picture
The Investor 17 Nov 2026, 09:07
Omeros Falls 4.3% After Hours Despite YARTEMLEA Revenue Growth

Omeros (NASDAQ: OMER) shares fell 4.3% in after-hours trading even as YARTEMLEA continued to post sequential revenue growth in the third quarter.

YARTEMLEA gross revenue rose 30% sequentially to $41.8 million, while net revenue increased 26% to $35.9 million. Excluding non-cash derivative adjustments, adjusted net income improved to $4.7 million, or $0.06 per share, from $1.8 million in the prior quarter.

However, GAAP results swung to a $57.4 million net loss, largely because of a $62.0 million non-cash mark-to-market loss tied to convertible notes. The company also disclosed that the EMA’s CHMP issued a negative opinion on narsoplimab’s European marketing application after re-examination.

The after-hours decline appears to reflect investor concern around the European regulatory setback and headline GAAP loss, despite continued YARTEMLEA growth and positive operating cash flow.

Comments

No comments yet.

Ana sayfa